Home Compare COLO-B.CO vs IDXX
Stock Comparison · Structural lead, mixed market

Coloplast A/S vs IDEXX Laboratories: Which Stock Looks Stronger in 2026?

IDEXX Laboratories holds the cleaner structural position, with the lead spread across growth and profitability. Coloplast A/S still has the edge on stability, which keeps the comparison from looking entirely one-sided. Both sides have seen trend damage — neither carries a clear market edge right now. With both trends damaged, the structural comparison carries most of the weight here.

The comparison is based on similar long-term financial trajectories, not sector labels.

Updated 2026-04-05

This is not just a one-metric split: both growth and profitability materially support the lead. IDEXX Laboratories, Inc. leads by 17 points on the overall comparison score.

Trajectory Similarity
0.68
Moderately similar
Peer-set rank: #7
within Coloplast A/S's functional peer set

This comparison is anchored in long-term financial trajectory similarity within the selected peer universe.

The pair shares a valid long-term profile match, but the trajectories are not especially close.

The clearest structural overlap shows up in revenue stability and capital structure.

Similarity drivers
revenue stabilitycapital structure
How to read the score
0.85–1.00 · Very similar0.70–0.84 · Similar0.55–0.69 · Moderately similarbelow 0.55 · Loose match
Peer-Relative Score
COLO-B.CO
Coloplast A/S
53
Peer-Score
Signal qualityHigh
vs
IDXX
IDEXX Laboratories, Inc.
70
Peer-Score
Signal qualityHigh

Scores reflect position relative to comparable companies with similar long-term financial trajectories.

The largest gaps do not all point in the same direction.

Dimension spread: COLO-B.CO vs IDXX Profitability 57 93 Stability 56 44 Valuation 54 49 Growth 44 94 COLO-B.CO IDXX
Gap Ranking
#1 Growth +50
#2 Profitability +36
#3 Stability +12
#4 Valuation +5
Price Setup

Left means cheaper relative valuation. Higher means stronger structure.

Price setup map for COLO-B.CO and IDXX Stronger + cheaper Stronger + richer Weaker + cheaper Weaker + richer COLO-B.COIDXX Relative valuation Structural strength

IDEXX Laboratories, Inc. occupies the cheaper side of the setup map, although Coloplast A/S still holds the stronger structural profile.

Valuation position uses peer-relative PE percentile (idx_pct_pe) where available.

Relative Position vs Comparable Companies
Growth
Both rank well on growth, but IDEXX Laboratories, Inc. still holds a clear edge.
Profitability
On profitability, the edge is clear — both rank well, but IDEXX Laboratories, Inc. sits noticeably higher.
Growth — Dominant Gap
COLO-B.CO
44
IDXX
94
Gap+50in favour of IDXX

The main growth separation is very wide, driven by a meaningfully stronger expansion profile.

What keeps the gap from being one-sided

Coloplast A/S still looks less cycle-sensitive — that keeps the result from looking completely one-sided.

What this means for the comparison

The lead is built on both growth and profitability — though stability still provides a counterweight.

Explore full peer positioning in AssetNext

Break down the COLO-B.CO vs IDXX comparison across all dimensions with the full interactive tool.

Explore full breakdown →
Similar growth-and-profitability comparisons

Explore how COLO-B.CO and IDXX each compare against other companies in their peer groups.

Rule-based, descriptive analysis only. Derived from peer percentile dimensions. Not investment advice. Peer groups are determined algorithmically based on structural similarity — not by sector classification alone.

How AssetNext Peer Scores Work

AssetNext scores reflect each company's structural position within its functional peer group — not a ranking against all stocks simultaneously. Peers are identified by similarity across eight financial dimensions, including revenue growth trajectory, margin structure, capital intensity, and earnings stability. A score of 75 means the company ranks in the top quartile within its own peer group, not the entire market.

Four dimension scores drive the overall peer score: Growth (revenue trajectory and expansion dynamics), Quality (margin structure and capital efficiency), Valuation (peer-relative pricing on standard multiples), and Stability (earnings consistency and financial predictability). Each dimension is scored 0–100 relative to the peer group, then combined into an overall peer score using equal weighting.

Scores are recalculated periodically as underlying financial data is updated. All analysis is descriptive and rule-based — AssetNext describes structural realities and never issues buy, sell or hold recommendations.